SCHEMBL6173889

SCHEMBL6173889

CC1(Cc2ccnc(NS(C)(=O)=O)c2)NC(=O)N(c2ccc(S(=O)(=O)C(F)(F)F)cc2)C1=O

nearest known ligand 0.50

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 12/20 0.50
AR P10275 2/20 0.39
ITGAL P20701 1/20 0.37
KMT2A Q03164 2/20 0.36
KIF11 P52732 1/20 0.35
TSHR P16473 1/20 0.34
TP53 P04637 1/20 0.34
KIT P10721 1/20 0.34
BRAF P15056 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6175526 0.92 IGF1R (0.42) IGF1RARITGALKMT2ATSHR
SCHEMBL6172714 0.90 IGF1R (0.41) IGF1RARITGALKMT2ATSHR
SCHEMBL6172219 0.89 MAPT (0.42) IGF1RARITGALKMT2ATP53
SCHEMBL6175060 0.87 IGF1R (0.41) IGF1RARITGALKMT2ATSHR
SCHEMBL6169398 0.86 IGF1R (0.49) IGF1RARITGALKMT2AKIF11
SCHEMBL6173575 0.85 IGF1R (0.44) IGF1RARITGALKMT2ATSHR
SCHEMBL6175372 0.84 IGF1R (0.41) IGF1RARKMT2A
SCHEMBL6174483 0.83 IGF1R (0.42) IGF1RARITGALKMT2ATSHR
SCHEMBL6175004 0.83 IGF1R (0.42) IGF1RARITGALKMT2ATSHR
SCHEMBL6176511 0.83 NAMPT (0.43) IGF1RKITBRAF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed